Cargando…

Long-term Persistence of Neutralizing Antibodies to SARS-CoV-2 Following Infection

Detalles Bibliográficos
Autores principales:	Wisnivesky, Juan P., Stone, Kimberly, Bagiella, Emilia, Doernberg, Molly, Mendu, Damodara Rao, Lin, Jenny J., Kale, Minal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Concise Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330817/ https://www.ncbi.nlm.nih.gov/pubmed/34346008 http://dx.doi.org/10.1007/s11606-021-07057-0

Ejemplares similares

Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City
por: Mansour, Mayce, et al.
Publicado: (2020)

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
por: Wajnberg, Ania, et al.
Publicado: (2020)

Association of Vaccination with the Persistence of Post-COVID Symptoms
por: Wisnivesky, Juan P., et al.
Publicado: (2022)

Demographic Characteristics of Adults with IgG Antibodies to Prior Symptomatic SARS-CoV-2 Infection
por: Mansour, Mayce, et al.
Publicado: (2021)

Persistence and Waning of Natural SARS-CoV-2 Antibodies Over 18 Months: Long-Term Durability of IgG Humoral Response in Healthcare Workers
por: Varona, Jose F., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust
por: Grant, Joseph J., et al.
Publicado: (2020)

Anti-SARS-CoV-2 antibodies following vaccination are associated with lymphocyte count and serum immunoglobulins in SLE
por: Reynolds, John A, et al.
Publicado: (2023)

Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound
por: Cale, Evan M., et al.
Publicado: (2020)

Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
por: Kohler, Philipp P., et al.
Publicado: (2020)

Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection
por: Bosserman, Rachel E., et al.
Publicado: (2022)

Assessment of Cognitive Function in Patients After COVID-19 Infection
por: Becker, Jacqueline H., et al.
Publicado: (2021)

Long‐term persistence of neutralizing SARS‐CoV‐2 antibodies in pets
por: Decaro, Nicola, et al.
Publicado: (2021)

Atopic dermatitis is not associated with SARS-CoV-2 outcomes
por: Rakita, Uros, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in a healthcare worker population exceeded self-reported infection rates, 2020
por: Hoover, Susan E., et al.
Publicado: (2022)

Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum
por: Chen, S., et al.
Publicado: (2005)

Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure
por: Hunter, Benton R., et al.
Publicado: (2020)

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infections occurring in healthcare workers after booster vaccination: A comparison of delta versus omicron variants
por: Reeves, Kimberly D., et al.
Publicado: (2022)

Development and characterization of a quantitative ELISA to detect anti-SARS-CoV-2 spike antibodies
por: Żak, Magdalena M., et al.
Publicado: (2021)

SARS‐CoV‐2 research using human pluripotent stem cells and organoids
por: Deguchi, Sayaka, et al.
Publicado: (2021)

Evaluation of appropriate transmission-based precautions for non-SARS-CoV-2 respiratory viruses
por: Falk, Cassandra L., et al.
Publicado: (2023)

Longitudinal analysis of risk factors associated with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among hemodialysis patients and healthcare personnel in outpatient hemodialysis centers
por: Gandra, Sumanth, et al.
Publicado: (2022)

Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area
por: Lewis, Sarah S., et al.
Publicado: (2020)

Vaccine breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota, and Omicron
por: Martínez-González, Brenda, et al.
Publicado: (2022)

HIV-1 replicates and persists in vaginal epithelial dendritic cells
por: Pena-Cruz, Victor, et al.
Publicado: (2018)

Persistence of the neutralizing antibody response after SARS-CoV-2 infection
por: Shim, Sang-Mu, et al.
Publicado: (2022)

Sensitivity of midturbinate versus nasopharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Jamal, Alainna J., et al.
Publicado: (2020)

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) screening among symptom-free healthcare workers
por: Demmer, Ryan T., et al.
Publicado: (2021)

Linking sporadic hospital clusters during a community surge of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) B.1.617.2 delta variant: The utility of whole-genome sequencing
por: Wee, Liang En, et al.
Publicado: (2023)

Acute Myocardial Injury During SARS-CoV-2 Pneumonia and Long-term Prognosis
por: Sanz, Francisco, et al.
Publicado: (2022)

Assessing severe acute respiratory coronavirus virus 2 (SARS-CoV-2) preparedness in US community hospitals: A forgotten entity
por: Advani, Sonali D., et al.
Publicado: (2020)

Comprehensive investigation of an in-hospital transmission cluster of a symptomatic SARS-CoV-2–positive physician among patients and healthcare workers in Germany
por: Wendt, Ralph, et al.
Publicado: (2020)

Environmental surface testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during prolonged isolation of an asymptomatic carrier
por: Shin, Kyeong Seob, et al.
Publicado: (2020)

Estimating the predictive value of negative severe acute respiratory coronavirus virus 2 (SARS-CoV-2) results: A prospective study
por: Hirschwerk, David, et al.
Publicado: (2020)

Crusted Scabies in Systemic Sclerosis with Plasma Cell Dyscrasia
por: Nikam, Balkrishna P., et al.
Publicado: (2018)

Air contamination of households versus hospital inpatient rooms occupied by severe acute respiratory coronavirus virus 2 (SARS-CoV-2)–positive patients
por: Munoz-Price, L. Silvia, et al.
Publicado: (2021)

Impact of on-site compared to off-site testing for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) on duration of isolation and resource utilization
por: Roberts, Andrew T., et al.
Publicado: (2020)

Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021
por: Graciaa, Daniel S., et al.
Publicado: (2022)

Mitigating healthcare staffing shortages: Should healthcare workers with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) household exposures work?
por: Blanchard, Ana C., et al.
Publicado: (2023)

Know your enemy: Unexpected, pervasive and persistent viral and bacterial contamination of primary cell cultures
por: Niehues, Hanna, et al.
Publicado: (2020)

Persistence of potential ST398 MSSA in outpatient settings among US veterans, 2010–2019
por: Carrel, Margaret, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f47fk5atokic554823goced76i